FDA issued a proposed rule on labeling requirements for OTC human drugs. The announcement proposed a definition for “convenience-size” OTC drug packages as well as the option of alternative labeling requirements for these products. CHPA welcomes the opportunity to comment on the proposed rule changes.
The PCPC and CHPA are pleased to provide these comments in response to FDA's proposed amendment to the final monograph for OTC sunscreen drug products for human use.
This meta-analysis aimed to compare single-dose 10 mg phenylephrine and placebo separately in adult patients with acute nasal congestion due to the common cold.
This summary report presents the key findings of a national survey of American adults regarding the use of over-the-counter cough remedies to alleviate cough symptoms resulting from the flu, a cold, or other respiratory ailment.
Request for extension of comment period regarding Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs.
